Scientific consulting firm Exponent (NASDAQ:EXPO) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with ...
Sold 344,631 shares of Exponent, representing an estimated $24.63 million based on the average price for the third quarter ended September 30, 2025 After the sale, the fund holds 2,361,196 shares ...
MENLO PARK, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (EXPO) today reported financial results for the fourth quarter and fiscal year 2025 ended January 2, 2026. “We delivered a strong ...
Q4 Revenue Growth Strengthens Despite Calendar Headwinds Exponent delivered a solid top line in the fourth quarter of 2025, with total revenues up 8% year over year to $147.4 million and net revenues ...
Exponent is a business that we have admired from the sidelines for a while, and we finally saw an opportunity to initiate a position at an attractive price due to a rare pause in annual growth. No ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results